The Expressions of Musashi-2 and CD133 Protein in Colonic Adenocarcinoma
10.3969/j.issn.0253-9896.2013.12.005
- VernacularTitle:Musashi-2、CD133在结肠腺癌中的表达
- Author:
Yafei WANG
;
Zhong LIN
;
Qing LU
;
Laodong LI
;
Qiaoyan HOU
;
Jing TANG
- Publication Type:Journal Article
- Keywords:
colonic neoplasms;
adenocarcinoma;
immunohistochemistry;
Musashi-2;
CD133
- From:
Tianjin Medical Journal
2013;(12):1153-1155
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of Musashi-2 and CD133 in colonic adenocarcinoma,and their correlation with the occurrence and development of colonic adenocarcinoma thereof. Methods The expressions of Musashi-2 and CD133 protein were detected by immunohistochemical method in 40 colonic adenocarcinoma samples and 15 normal colonic structure samples. The different histological types, TNM staging, lymph node metastasis, serous infiltration, distant metastasis and expressions of Musashi-2 and CD133 proteins in colonic adenocarcinoma tissues were analyzed. Results The positive expression rates of Musashi-2 and CD133 protein were 60%and 27.5%in 40 colonic adenocarcinoma samples and 26.7%and 0 in 15 normal colonic samples, which showed the significantly higher expression rates in colonic adenocarci-noma group than those of control group (χ2=4.850 and 5.156,P<0.05). There were significant differences in expressions of Musashi-2 proteins between different histological stages and TNM staging (P<0.05). The positive expression rate of Musa-hi-2 protein increased as the degree of differentiation decreased and TNM stage increased. There were significant differenc-es in expressions of CD133 proteins between different histological stages and lymph node metastasis (P<0.05). The positive expression rate of CD133 protein increased as the degree of differentiation decreased and lymph node metastasis occurred. Conclusion The expression of Musashi-2 and CD133 may be related with the initiation and development of colonic can-cer, which can be used as the stem cell markers of colonic adenocarcinoma for the further study.
